FDA Approves Maternal RSV Vaccine Designed To Protect Infants

Reuters (8/21, Wingrove, Satija) reports, “The U.S. Food and Drug Administration on Monday approved Pfizer’s respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.” The go-...